Heron Therapeutics HRTX
NASDAQ HRTX
$0.35 -0.01 (-2.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Heron Therapeutics (HRTX) reported Depreciation & Amortization (CF) of $452,000 for Q2 2026, down 26.0% from $611,000 a year earlier and down 14.6% from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Heron Therapeutics' Depreciation & Amortization (CF) came in at $2.13 million, down 8.5% year-over-year; for FY2025, it came in at $2.31 million, down 7.4% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $2.5 million in FY2024 (-13.8%), $2.9 million in FY2023 (+0.4%), $2.89 million in FY2022 (-4.4%) and $3.02 million in FY2021 (+6.1%).
  • The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q4 2018.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last three quarters, with an average decline of 11.9% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2021 (growth of 11.5%); the low point was Q2 2026 (a decline of 26.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $529,000 (Q1 2026), $537,000 (Q4 2025) and $615,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Heron Therapeutics 68.35 Mn -121.22 Mn 26.09 Mn 452,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 452,000.00
Mar 31, 2026 529,000.00
Dec 31, 2025 537,000.00
Sep 30, 2025 615,000.00
Jun 30, 2025 611,000.00
Mar 31, 2025 551,000.00
Dec 31, 2024 589,000.00
Sep 30, 2024 581,000.00
Jun 30, 2024 641,000.00
Mar 31, 2024 689,000.00
Dec 31, 2023 716,000.00
Sep 30, 2023 727,000.00
Jun 30, 2023 739,000.00
Mar 31, 2023 718,000.00
Dec 31, 2022 791,000.00
Sep 30, 2022 706,000.00
Jun 30, 2022 671,000.00
Mar 31, 2022 721,000.00
Dec 31, 2021 794,000.00
Sep 30, 2021 754,000.00
API Access

Heron Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=HRTX&period=max&api_key=YOUR_API_KEY